Genetic evidence and host immune response in persons reinfected with SARS-CoV-2, Brazil

• Autor(a) principal: Rodrigues, Natalia Fintelman
• Data de Publicação: 2021
• Outros Autores: Silva, Aline P.D. da, Santos, Monique Cristina dos, Saraiva, Felipe, Ferreira, Marcelo, Gesto, João, Rodrigues, Danielle A.S., Vale, André, Azevedo, Isaclaudia de, Soares, Vinícius, Jiang, Hui, Tan, Hongdong, Tschoeke, Diogo A., Sacramento, Carolina, Bozza, Fernando A., Morel, Carlos Medicis, Bozza, Patrícia Torres, Souza, Thiago Moreno L.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
• Texto Completo: https://wwwnc.cdc.gov/eid/article/27/5/20-4912_article; https://www.arca.fiocruz.br/handle/icict/46571
• topic: Coronavirus Infections; Brazil; COVID-19; SARS-CoV-2; Reinfecção; Brasil; COVID-19; SARS-CoV-2; Reinfected; Brazil; Infecções por Coronavirus; Brasil

We thank Carmen Beatriz Wagner and Giacoia Gripp for assessments related to the Biosafety Level 3 facility and Marco Alberto Medeiros for assessments related to the sequencing platform. We thank Gonzalo Bello, Dumith Chequer Bou-Habib, Willian Provance, and Fabiano Thompson for insightful discussions. We greatly appreciated the MGI, a partner in the implementation of next-generation sequencing through collaborations with Oswaldo Cruz Foundation, especially for challenging samples of COVID-19. Author contributions: F.A.B. and P.T.B. conducted clinical surveillance. N.F.R. and F.A.B. enrolled patients in the study. N.F.R., C.Q.S., D.R., I.G.A., V.C.S. performed immunologic assessments. N.F.R., A.P.D.S., M.C.S., F.B.S., M.A.F., J.G., H.J., and H.T. performed sequencing. A.P.D.S., M.C.S., and D.A.T were responsible for bioinformatics. F.A.B., P.T.B., C.M.M., T.M.L.S. handled study coordination. N.F.R., P.T.B., A.MV., and T.M.L.S. prepared and revised the manuscript. All authors revised and approved the manuscript.